Fatal myocardial fibrosis in an aged chimpanzee (Pan troglodytes) by Audrey Baldessari et al.
Fatal myocardial ﬁbrosis in an aged chimpanzee
(Pan troglodytes)
Audrey Baldessari
1*, Jessica Snyder
2, Joel Ahrens
1 and Robert Murnane
1
1Washington National Primate Research Center, University of Washington, Seattle, WA, USA;
2Department of Comparative Medicine, University of Washington, Seattle, WA, USA
A 36-year-old male chimpanzee (Pan troglodytes) assigned to a life-long sign language communication project
presented for sudden death. No other clinical or clinical pathological abnormalities were noted and given the
signalment, death due to cardiac failure was suspected. Necropsy findings revealed moderate cardiomegaly
and other chronic age-related findings including focal renal tubular cystic dilation and gingival hyperplasia.
Histologic evaluation of the heart revealed interstitial fibrosing cardiomyopathy characterized by severe
interstitial myocardial fibrosis replacing and separating myofibers within all chambers of the heart, especially
the left ventricle, interventricular septum and subvalvular areas. This case report represents an additional case
of sudden death associated with interstitial myocardial fibrosis in a chimpanzee. This process has been
previously cited as the most common cause of sudden death in aged chimpanzees.
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S
udden death associated with heart failure is de-
scribed as the most common cause of death in
captive populations of chimpanzees and has been
described in other great apes including gorillas and
orangutans (14). The most common pathologic lesion
is interstitial fibrosing cardiomyopathy, and sudden death
is thought to be associated with defective conduction or
sudden cardiac arrhythmias.
Several mechanisms may contribute to age-related
cardiac fibrosis, including recruitment and activation of
resident fibroblasts and fibroblast precursors influenced
by various molecular signaling pathways such as the
endothelial-mesenchymal transition mediated by TGF-b
or bone marrow-derived circulating stem cells and
monocytes (5,6), and impaired reparative responses
including reduced collagen degradation in the remodeling
process and altered collagen cross-linking. Cardiomyo-
cytes are inherently rich in mitochondria, which generate
reactive oxygen species as a by-product of oxidative
phosphorylation, influencing cytokine signaling and
fibroblast metabolism (7). The mechanisms of myocardial
fibrosis likely differ in the diseased, ischemic or pressure-
overloaded heart as compared to the heart of a normal,
aging individual.
Due to the genetic similarities, cardiac disease in aging
humans has been compared to heart failure in great apes,
especially the chimpanzee. The differences in presentation
and lesion characteristics between non-human primates
and human cardiac disease are striking in that aging
chimpanzees develop a network of interstitial collagen
without apparent vascular disease or myofiber injury,
whereas humans typically acquire vascular occlusive dis-
ease over the course of their lives which leads to ischemic
injury to myocardial fibers (8). Other non-human primate
species in research settings develop varying degrees and
severity of cardiac disease if fed an atherogenic diet, but
with the exception of some New World primate species,
rarely develop atherosclerotic changes when fed a diet
similar to their foraging counterparts (9).
Case report
A 36-year-old male chimpanzee (Pan troglodytes) pre-
sented to the Washington National Primate Research
Center for postmortem examination following sudden
and unexpected death. For the past 31 years, the animal
had been housed in an indoor/outdoor facility at the
Central Washington University Chimpanzee and Human
Communication Institute. The animal was maintained in
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for the Care and Use of Laboratory Animals (10). This
chimpanzee was part of a sign language and commu-
nication research group and was closely monitored on
a daily basis. There was history of a single episode of
vomiting the prior week. No other premonitory signs
were noted by either the research staff or clinical
veterinarian. The male partner of the deceased animal
inflicted postmortem integumentary wounds to the face,
ventral thorax and scrotum. Differential diagnoses at
presentation for postmortem examination included car-
diac disease or a vascular event, such as an aneurysm,
pulmonary thromboembolism, or stroke.
Pathology
At necropsy, body weight appeared normal and was
approximately 160 lbs (72.7 kg). There was moderate
postmortem autolysis. Externally, there was marked,
multifocal gingival hyperplasia and dorsal displacement
of the right maxillary canine tooth. Multifocal, post-
mortem skin abrasions and lacerations were present
ventrally, focused on the perioral and scrotal areas. The
heart was diffusely, moderately enlarged (Fig. 1A), with a
weight of 497.3 g and displacement of 217 cm
3. There
were multifocal, firm pale streaks (scarring) predomi-
nantly within the left ventricular free wall, interventri-
cular septum, and apex of the heart, with similar though
less prominent lesions seen in all chambers (Fig. 1B). The
right ventricle was mildly dilated. Other lesions included
a focal, discrete 2 cm diameter, multicystic lesion in the
right renal cortex. Minor to moderate multifocal fibrous
adhesions were noted between the loops of the small
intestine and between the small and large intestine.
Tissues were fixed in 10% neutral buffered formalin,
processed routinely, embedded in paraffin and stained
with hematoxylin and eosin (H&E). Histologic examina-
tion of the heart revealed multifocal, moderate to severe,
mostly mature fibrosis separating and replacing myofi-
bers in all chambers (Fig. 1C and D). Islands of mature
adipose tissue were also present in the fibrotic areas,
especially within the atria. There was significant fibrosis
at the base of the mitral valve. Trichrome staining re-
vealed abundant blue stained collagen separating remain-
ing myofibers (Fig. 1E). There were small numbers of
lymphocytes and histiocytes diffusely spread within the
areas of fibrosis or surrounding degenerate myofibers
and within the epicardial connective tissue. Multifocal,
moderate to marked anisokaryosis was seen within the
remaining myofibers. Minimal, light brown, perinuclear
granular pigment (lipofuscin) was seen in scattered
myocytes. Rare, minimal to mild atherosclerotic changes
were seen in random coronary arterioles, characterized
by few mural macrophages, foamy cells and eosinophilic
matrix material. Other age-related findings included
a focal nodule of renal cortical tubular ectasia and
few renal cortical infarcts with fibrosis and chronic
inflammation (Fig. 1F). Brain was not available for
examination.
Discussion
Sudden cardiac death has been previously described in
great apes and the prevalence of sudden death associated
with heart disease in chimpanzees has been reported to be
as high as 68% in captive adult populations, with males
more often affected than females (3,8,1113). This case
represents an aged adult male chimpanzee that died
unexpectedly of heart disease. With the exception of a
singleepisodeofvomiting,noclinicalsignswereseenprior
to death and clinical pathology data were not available.
The heart weight-to-body weight ratio (0.0068) observed
postmortem was consistent with moderate cardiomegaly,
with a previously reported mean heart weight-to-body
weight ratio in chimpanzees with grossly and microscopi-
cally normal hearts of 0.0052 (1). Significant remodeling
of the interstitium was seen microscopically. In the largest
casereport describingagroupof36animals,36%ofwhich
died of sudden cardiac death, the average age of animals
with moderate cardiac fibrosiswas 28.9 yearswith a range
2140 years (1). This disease is typically reported retro-
spectively as controlled studies of cardiac disease are not
possible in this species. Death in these cases is speculated
to be due to conduction abnormalities.
The predominant histologic lesion in this animal was
moderate to severe interstitial cardiac fibrosis. Similar to
other case reports of sudden cardiac death with fibrosis
(13), the coronary arteries lacked evidence of significant
atherosclerotic changes. Atherosclerosis in humans is
considered to be an inflammatory disorder with chronic
inflammation of coronary arteries occurring secondary
to metabolic changes such as an atherogenic lipid profile
(elevated low-density lipoprotein [LDL] and cholesterol,
and decreased high-density lipoprotein [HDL] associ-
ated with aging). Such arterial changes lead to sudden
coronary arterial occlusion or chronic partial occlusion
with ischemia, remodeling, and fibrosis via repair me-
chanisms. There have been comparisons between inter-
stitial myocardial fibrosis in chimpanzees and other great
apes, and humans, although the latter tend to develop
scarring and fibrosis secondary to vascular disease with
infarction and ischemia (1). Despite the close genetic rela-
tionships between humans and great apes, and the similar
progressive weight gain and atherogenic lipid profile with
age in male chimpanzees (14), the etiology of cardiac
fibrosis in apes does not appear to be vascular in origin.
The amount of interstitial inflammation observed in
non-human primate cases varies within the literature
but was mild in this case. An infectious process such as
Trypanosoma cruzi or viral disease was considered
unlikely because no histological evidence was present
and the chimpanzee did not have a compatible travel
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with cardiac fibrosis in one chimpanzee and was thought
to be associated with chronic inflammation although no
histologic examination was described in that retrospective
report (2). Often no significant inflammation or athero-
sclerosis is seen in these cases (1,3,8).
Dietary differences may play a role in the lack of
development of atherosclerotic lesions, as the majority of
non-human primates in captivity consume a commercial
primate diet, which is typically low fat (approximately
510%) and supplemented with fruits and vegetables.
The average LDL of Americans is 130 mg/dl, while free
ranging baboons on a foraging diet have reported values
of 4080 mg/dl (15). However, adult captive non-human
primates tend to weigh more than their corresponding
free ranging species and in captivity, like humans, tend to
become obese with age. Lipid profiles of both groups also
tend to change similarly with age (14,16,17). It is reported
Fig. 1. (A). Chimpanzee heart. Note the diffuse cardiomegaly, (B) cut section of the myocardium. Note the thick streaks of pallor
within the papillary muscles, (C) interstitial myocardial ﬁbrosis, with pale staining collagen separating myoﬁbers, 40, H&E, (D)
interstitial myocardial ﬁbrosis with adipose tissue inﬁltrates and mild chronic inﬂammation, 100, H&E, (E) interstitial myocardial
ﬁbrosis; note the abundant blue staining collagen bands, 40, trichrome stain, (F) chronic renal infarct with interstitial nephritis and
ﬁbrosis, 100, H&E.
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(Macaca mulatta), do not develop atherosclerosis natu-
rally, they do form atherosclerotic plaques if fed an
atherogenic diet resulting in hypercholesterolemia (9,18).
Cynomolgous macaques (Macaca fascicularis) have been
shown to display a marked difference in development of
atherosclerotic lesions related to age, with young animals
(2.53.5 years of age) showing less coronary artery lesions
despite similar serum lipid concentrations as compared to
adults (612 years of age) (19,20). Other metabolic
factors that tend to change with age such as central
obesity (waist circumference), hyperinsulinemia, accumu-
lation of glycation end products, and increased blood
pressure, all play a role in human coronary vascular
disease. Glucose tolerance decreases with age, and glyca-
tion end products have been shown to accumulate in
arteries even in non-diabetic cynomolgous monkeys
(9,19) but this has not been studied in chimpanzees.
Early diagnosis of heart disease may assist in clinical
management. In human medicine, investigation into the
potential uses of biomarkers of inflammation, oxidative
stress, myocyte injury, and collagen metabolism has been
investigated (21). In one report, brain-type natriuretic
protein, a peptide which correlates positively with in-
creased cardiac wall tension and heart enlargement, and
cardiac troponin I, which is released due to myocardial
necrosis, were both elevated in 28 cases of various types
of cardiovascular disease in chimpanzees (17). C-reactive
protein and a lipid panel, including cholesterol, LDL and
triglycerides, were not useful clinically in the diagnosis of
heart disease in chimpanzees, although the lipids notably
increased with age (17). Biomarkers of collagen metabo-
lism have been investigated for potential use in the clinical
management of great apes. A human assay for matrix
metalloproteinase-1 did not cross-react with chimpanzee
sera but initial carboxy terminal telopeptide and pro-
collagen III n-terminal protein did increase in cases of
cardiovascular disease that had concurrent renal dis-
ease (22). Approximately two thirds of the cells in the
myocardium are fibroblasts, which compose a variable
proportion of the heart volume and influence cell
signaling between cardiomyocytes via the extracellular
matrix and molecular chemical mediators (23,24). In
health, type I collagen predominates (approximately 80%)
and type III collagen comprises approximately 20%, with
lesser amounts of type IV collagen. Alterations in the
proportions of collagen may lead to changes in cardiac
elasticity (25); however, no data are found specifically on
changes in collagen types in cases of cardiac fibrosis in
great apes. Collagen breakdown products are not specific
to cardiac fibroblasts and heart disease, and may also
increase in association with collagen turnover at other
sites (26), and rates of collagen breakdown may not
correlate with collagen deposition in the myocardial
interstitial space. Due to the clinically silent nature of
fibrosing cardiomyopathy in great apes, a screening test
or panel that is reactive with primate sera, and both
specific and sensitive would be ideal, however, more work
is needed in this area. Other measures such as blood
pressure and functional parameters including heart rate,
cardiac output, and mural compliance may be helpful to
characterize cardiac function in aging chimpanzee popu-
lations with a goal of detecting developing heart disease
at earlier stages.
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